<DOC>
	<DOCNO>NCT02119780</DOCNO>
	<brief_summary>This study purpose evaluate efficacy safety YVOIRE® contour compare Restylane SubQ™ inject anteromedial malar region .</brief_summary>
	<brief_title>Clinical Study Evaluate Efficacy Safety YVOIRE® Contour Compared With Restylane SubQ™ Injected Into Anteromedial Malar Region</brief_title>
	<detailed_description />
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Be male female , 2065 year age Have anteromedial malar region volume loss grade 2 , 3 , 4 Mid Face Aesthetic Scale ( MFAS ) symmetrically side Desire filler treatment correct volume loss anteromedial malar region Accept obligation receive mid facial procedure treatment study Signed informed consent Those fall one follow 3 case 1 . Males females surgically sterile 2 . Postmenopausal females 45 year age 2 year last menstruation 3 . Fertile premenopausal female male without surgical sterilization , agree use least two contraception method ( one barrier method must include ) 14 day last treatment investigational device avoid pregnancy Have history hypertrophic scar keloids Other criterion identify protocol</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>